Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index; 6 of the 29 sources its claims cite were checked for support.
Abstract
Purpose: This analogue pilot study examined the feasibility (i.e. preliminary results, safety, acceptability) of a new single-session treatment for adults with a fear of spiders. Materials: It used state-of-the-art consumer available VR-hardware for therapist-assisted exposure (VRET–AP). The VRET-AP is largely adapted from Öst’s one-session treatment for arachnophobia (Öst, 1987), with the aim of addressing shortcomings of previous VRET treatments, such as marked differences in procedures compared to available and evidence based in-vivo treatments. Method: Participants (N = 12) were screened for fear of spiders using the Spider Phobia Questionnaire (SPQ), Fear Questionnaire (FQ) and the Behavioral Approach Test (BAT), prior to and directly after treatment in a repeated measures quasi-experimental design. In addition, acceptance and completion rates were measured and participants were interviewed about their experience of the treatment. Mean ratings as well as Reliable Change Index (RCI) for individual trajectories were analyzed. Results: The results from the preliminary data indicates potential for improvements with large effect sizes (d = 0.90-1,384) in all measurements of spider fear at post-treatment. Reliable Change Index (RCI) analysis showed that spider fear diminished in all twelve participants although the change was certain in only two. None deteriorated. All that responded accepted the treatment and all 11 participants completed all levels in the treatment. No concerns or adverse effects were reported in the interviews which largely confirm the quantitative results. Conclusion: VRET-AP is a feasible alternative for delivering effective treatment for fear of spiders and the results motivate larger, randomized trials of VRET-AP involving participants diagnosed with arachnophobia. © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Overview
CoChat Summary
TL;DR
This uncontrolled analogue pilot tested therapist-led virtual reality exposure therapy for arachnophobia (VRET-AP) in 12 women and found significant pre-to-post reductions on spider fear measures with large within-group effect sizes. Treatment was mostly accepted and completed, with no reported adverse effects or cybersickness, but the authors caution that randomized trials are needed.
Key findings
- Table 1 reports SPQ decreased from M = 18.30 (SD = 4.03) to 13.80 (2.97), p = .002, d_av = 1.01; FQ main phobia decreased from M = 6.50 (.90) to 5.25 (1.28), p = .009, d_av = 0.99; FQ full range did not change, t(11) = 1.593, p = .139.
- BAT improved from M = 6.40 (2.59) to 10.00 (1.25), p = .003, d_av = 1.39; mean improvement was 3.6 steps (SD = 2.80), t(9) = -3.593, p = .004, d_av = 1.385. Eight of ten participants who completed post-treatment BAT reached step 10–12 of 12 (touching or holding the spider), and all could remove the lid. An intention-to-treat mixed model confirmed improvement, t(17.935) = 23.287, p < .001, B = 10.00, 95% CI [9.10, 10.90].
- All who responded accepted treatment; 11 of 12 completed all levels, with one opting out due to fatigue from ongoing pregnancy and long treatment duration. No cybersickness or adverse effects were reported in interviews.
- RCI analysis showed no participant deteriorated; all RCI scores were in the direction of improvement, but most change scores fell between 1.96 and 0, so improvement was statistically uncertain for most. The abstract states change was certain in only two participants.
Methods
- Uncontrolled analogue pilot/repeated-measures quasi-experimental design. N = 12 women aged 18–54 (M = 28.4), recruited via flyers or social media; inclusion was self-admitted fear of spiders, and exclusions were blindness and self-reported comorbid psychiatric illness. Baseline lasted at least five days, treatment lasted 2–4 h, and follow-up was 1–2 h one week after treatment.
- VRET-AP was delivered via an Oculus Quest 2 cable-connected to a gaming computer running Unreal Engine 4; therapist-assisted exposure had six levels (0–5) and was largely based on Öst’s one-session treatment. Measures were SPQ, FQ, and BAT, plus post-treatment semi-structured interviews analyzed with reflexive thematic analysis.
- Analysis used within-group paired t-tests (two-tailed for baseline stability, one-tailed for baseline-to-post), Cohen’s d_av, Reliable Change Index, and an intention-to-treat mixed-model regression for BAT missing data.
Limitations
- Stated by the paper: small sample, uncontrolled within-group comparisons, analogue sample without formal arachnophobia diagnosis, all female participants, volunteer recruitment selection bias, pre-to-post effects generally larger than in randomized controlled studies, possible confound from pre-treatment BAT spider exposure, therapist presence may introduce non-specific factors, technical/immersion issues (cable, blurriness, robotic hands, limited spider variation), and SuDS not systematically recorded.
- Evident from the text: no control group, no randomization, short one-week follow-up, reliance on self-report and behavioral measures, and small N limiting generalizability and statistical power.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
3 Valid · 1 Not valid · 17 Not checked · 90 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, most patients with specific phobias, including AP, do not seek treatment for this condition [9], possibly owing to fears about what treatment will involve [10].”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Introduction
What the sources say
- Supportedcites [9] 9. Wardenaar KJ, Lim CC, Al-Hamzawi AO, et al. The cross-national epide- miology of specific phobia in the world mental health surveys. Psychol Med. 2017;47(10):1744-1760. doi:10.1017/S0033291717000174. source
The Results > Treatment section (page not provided) reports that only 23.1% of 12-month specific phobia cases received any treatment. The Introduction also states that only a minority of patients seek treatment, and the paper includes animal phobia among the subtypes studied. (LLM, conf=0.92)
- Partly supportedcites [10] 10. Boeldt D, McMahon E, McFaul M, et al. using virtual reality expo- sure therapy to enhance treatment of anxiety disorders: identifying areas of clinical adoption and potential obstacles. Front Psychiatry. 2019;10:773. doi:10.3389/fpsyt.2019.00773. sourceExperimental — accuracy not yet measured
The Introduction (page not provided) says a majority of people affected by anxiety disorders remain untreated. It does not establish that most people with specific phobias, including AP, do not seek treatment; remaining untreated is not the same as not seeking it. The separate suggestion about fear of treatment is attached to citation [10], not this source. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“However, there is fairly large variance in treatment outcomes between different VRET studies”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Introduction
What the sources say
- Could not verifycites [17] 17. Brice D, Gibson Z, McGuinness F, et al. using ultrasonic haptics within an immersive spider exposure environment to provide a multi-sensorial experience. Front Virtual Real. 2021;2:107. doi:10.3389/frvir.2021.707731. sourceExperimental — accuracy not yet measured
The Discussion and section 2.2 discuss anxiety responses and findings from individual spider-VRET studies, but do not assess how much treatment outcomes vary between studies. Searches for cross-study variation in VRET treatment outcomes found no passage addressing that claim. (LLM, conf=0.73)
- Not checked — no full text of the sourcecites [18] 18. Miloff A, Lindner P, Dafgård P, et al. Automated virtual reality expo- sure therapy for spider phobia vs. in-vivo one-session treatment: a randomized non-inferiority trial. Behav Res Ther. 2019;118:130-140. doi:10.1016/j.brat.2019.04.004. source
- Not checked — no full text of the sourcecites [19] 19. Shiban y, Pauli P, Mühlberger A. Effect of multiple context exposure on renewal in spider phobia. Behav Res Ther. 2013;51(2):68-74. doi:10.1016/j.brat.2012.10.007. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Research show that treating specific phobia in VRET can be equally effective as standard in-vivo exposure therapy [15,16], with a recent meta-analysis suggesting marginally lower drop-out rates in VRET than standard CBT (16% vs 19.6%; 12].”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Introduction
What the sources say
- Supportedcites [15] 15. Freitas JRS, Velosa VHS, Abreu LTN, et al. Virtual reality exposure treatment in phobias: a systematic review. Psychiatr Q. 2021;92(4): 1685-1710. doi:10.1007/s11126-021-09935-6. source
The Acrophobia section says reviewed studies found VRET as effective as in-vivo exposure for reducing anxiety and avoidance of heights. The claim says VRET *can* be equally effective for a specific phobia, rather than claiming equivalence for every phobia. (LLM, conf=0.91)
- Supportedcites [16] 16. Oing T, Prescott J. Implementations of virtual reality for Anxiety-Related disorders: systematic review. JMIR Serious Games. 2018;6(4):e10965. doi:10.2196/10965. source
The Discussion’s Principal Findings state that VRET appears to have equal or greater efficacy for specific phobias and anxiety. The Results also report no significant difference between VRET and in-vivo exposure in a comparison involving agoraphobia. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“None deteriorated.”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Abstract
plainn = 12- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Reliable Change Index (RCI) analysis showed that spider fear diminished in all twelve participants although the change was certain in only two.”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Abstract
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
60 more claims
Create a free account to see all 111 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 26
- The quote only partly states this claim. 2
- It may state two separate claims as one. 27
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“t(9) = -3.593,p = .004”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Results
Reported p = .004 · recomputed p = .006
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upt(9) = -3.593reported p = .004 · recomputed p = .006
“t(9) = -3.593,p = .004”
- Consistentt(11) = 0.92reported p = .377 · recomputed p = .377
“t(11) = .920,p = .377”
- Consistentt(11) = -1.773reported p = .104 · recomputed p = .104
“t(11) = -1.773,p = .104”
- Consistentt(11) = 3.994reported p = .002 · recomputed p = .002
“t(11) = 3.994, p = .002”
- Consistentt(11) = 3.191reported p = .009 · recomputed p = .009
“t(11) = 3.191, p = .009”
2 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“A significant decrease (M = 18.42 to M = 14.25) in SPQ means ratings was found between pre-and post-treatment, t(11) = 3.994; p=.002 with mean change 4.5 (SD = 3.72)”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Results
Reported 4.5 · recomputed 4.17
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“a significant decrease in FQ main phobia mean ratings was found between pre-(M = 6.50) and post-treatment (M = 5.25), t(11) = 3.191, p = .009,with the effect size d av =0.99.The mean change was 0.5”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Results
Reported 0.5 · recomputed 1.25
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Results
“A significant decrease (M = 18.42 to M = 14.25) in SPQ means ratings was found between pre-and post-treatment”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Conclusion
“| sPQ | 18.30 (4.03) | 13.80 (2.97) | .002 | 1.01 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Completion and acceptability rates
“all but one of the 12 participants who choose to partake completed all levels in the treatment.”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Discussion
“of those treated all completed all levels during exposure.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Results
“BAT showed a significant mean increase (improvement) of 3.6 steps (SD = 2.80, range) at post-treatment, t(9) = -3.593,p = .004”
§ Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia > Conclusion
“| Bat | 6.40 (2.59) | 10.00 (1.25) | .003 | 1.39 |”
3 more findings
Create a free account to see every finding of this check.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Research show that treating specific phobia in VRET can be equally effective as standard in-vivo exposure therapy [15,16], with a recent meta-analysis suggesting marginally lower drop-out rates in VRET than standard CBT (16% vs 19.6%; 12].”
Cited work 10.2196/10965 · retraction date not known · this paper published 2023-11-21
Citations
Cites
1 retracted
Retracted: Implementations of Virtual Reality for Anxiety-Related Disorders: Systematic Review
Oing, T., & Prescott, J. (2018) · JMIR Serious Games · doi:10.2196/10965 · Cited by 157 · cited 1×
“Research show that treating specific phobia in VRET can be equally effective as standard in-vivo exposure therapy [15,16], with a recent meta-analysis suggesting marginally lower drop-out rates in VRET than standard CBT (16% vs 19.6%; 12].”
BackgroundInfluentialRetractedDiagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Reflecting on reflexive thematic analysis
Braun, V., & Clarke, V. (2019) · Qualitative Research in Sport, Exercise and Health · doi:10.1080/2159676x.2019.1628806 · Cited by 19,677 · cited 1×
“Interview data was analyzed by one of the therapists (JA) using reflexive thematic analysis [24] and later reviewed by and discussed in depth with the clinical senior researcher (JK).”
MethodLakens, D. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00863 · Cited by 10,303 · cited 1×
“Within groups Cohen’s d av effect sizes were calculated using the pre-and post treatment means and the average standard deviation of both repeated measures as a standardizer [26].”
MethodJacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770 · cited 1×
“It was based on the Jacobson and Truax model for clinical significance [27].”
MethodMaximizing exposure therapy: An inhibitory learning approach
Craske, M. G., Treanor, M., Conway, C. C., Zbozinek, T., & Vervliet, B. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.04.006 · Cited by 2,339 · cited 1×
“However, Craske and coworkers suggests that altering linear progression by introducing shifting of the order of exposure may further increases treatment outcome [32].”
BackgroundEnhancing Our Lives with Immersive Virtual Reality
Slater, M., & Sanchez-Vives, M. V. (2016) · Frontiers in Robotics and AI · doi:10.3389/frobt.2016.00074 · Cited by 1,993 · cited 1×
“Furthermore, Slater and Sanchez-Vives [31] found that for VR to be effective, the user need to feel an illusory sense of reality in the virtual environment.”
BackgroundCarl, E., Stein, A. T., Levihn-Coon, A., Pogue, J. R., Rothbaum, B., Emmelkamp, P., Asmundson, G. J. G., Carlbring, P., & Powers, M. B. (2019) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2018.08.003 · Cited by 889 · cited 1×
“…is that the preliminary results support our hypothesis and is reasonably well in line with previous studies on VR treatments of specific phobias [28,29], and also arachnopho-bia specifically such as Miloff and coworkers series of studies on a gamified exposure [8] Furthermore, Furthermore, we…”
ResultThe Role of Common Factors in Psychotherapy Outcomes
Cuijpers, P., Reijnders, M., & Huibers, M. J. H. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095424 · Cited by 748 · cited 1×
“Such factors may enhance the results independently of the intervention, though their impact, if any, are still under debate (for a meta-analysis and discussion of this topic, see 35].”
Background. Caution regarding the use of pilot studies to guide power calculations for study proposals.
Kraemer, H. C., Mintz, J., Noda, A., Tinklenberg, J., & Yesavage, J. A. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.484 · Cited by 702 · cited 1×
“Even though the results are encouraging, it must be noted that pre-to post effects generally are much larger than in randomized controlled studies [33,34], and therefore the large effect-sizes found here should be interpreted with great caution.”
Result
Research works printed but not linked: 1
- Miloff A. 2020). Virtual reality exposure therapy for spider phobia [doctoral dissertation]. Stockholm: Department of Psychology Stockholm University.
Cited by
Virtual Reality: Challenges and Perspectives in Mental Health
Machado, S. E. D. C., Paes, F., Ferreira-Garcia, R., Gonçalves, L. L., Carta, M. G., Appolinário, J. C., & Nardi, A. E. (2025) · ALPHA PSYCHIATRY · doi:10.31083/ap47536 · Cited by 15
Brachet, A., Biskupski, M., Hunek, G., Rusek, J., Bełżek, A., Forma, A., Teresiński, G., Sitarz, R., Karpiński, R., & Baj, J. (2025) · Applied Sciences · doi:10.3390/app152412941 · Cited by 13
Virtual reality delivered exposure for fear of needles: a small-scale pilot
Caltabiano, A., Burke, T., Nesi, J. L., Simplicio, M. C. D., & Zalk, N. V. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1642988 · Cited by 5
Willms, J., Sader, A., Juckel, G., & Mavrogiorgou, P. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116917 · Cited by 4
Prasad, A. A., Bidwai, S. L., Zawar, A. J., Ahuja, D. A., Kalatzis, A., & Prabhu, V. G. (2025) · INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION · doi:10.1145/3716553.3750761 · Cited by 2
“Virtual Reality Exposure Therapy (VRET), for example, treats anxiety disorders (e.g., specific phobias, Post-Traumatic Stress Disorder [PTSD], social anxiety) by systematically exposing individuals to challenging virtual scenarios like heights, public speaking, or combat simulations [2, 3, 13, 46].”
Metadata
- Authors
- Andersson, J., Hallin, J., Tingström, A., & Knutsson, J.
- Affiliations
- Lund University (SE)
- Corresponding author
- Knutsson, Jens
- Venue
- Nordic Journal of Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2023-11-21
- Volume
- 78
- Issue
- 2
- Pages
- 128-136
- ISSN
- 0029-1455 (ISSN-L)
- 0803-9488
- 1502-4725
- OpenAlex
- W4388866766
- Cited by
- 18
- References
- 35
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 2
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nordic Journal of Psychiatry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Lunds Universitet
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Physical Sciences › Computer Science › Human-Computer Interaction › Virtual Reality Applications and Impacts
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- virtual reality exposure therapy, spider phobia, single-session intervention, treatment feasibility, treatment acceptability, treatment safety
- MeSH terms
- Adult, Animals, Fear, Feasibility Studies, Humans, Phobic Disorders, Pilot Projects, Spiders, Virtual Reality Exposure Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia. https://app.cochat.ai/papers/10.1080/08039488.2023.2279643
- The paper
- Andersson, J., Hallin, J., Tingström, A., & Knutsson, J. (2024). Virtual reality exposure therapy for fear of spiders: an open trial and feasibility study of a new treatment for arachnophobia. Nordic Journal of Psychiatry. https://doi.org/10.1080/08039488.2023.2279643
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


